Davis's Drug Guide
topotecan
General
High Alert Medication: This medication bears a heightened risk of causing significant patient harm when it is used in error.
Pronunciation:
toe-poe-tee-kan
To hear audio pronunciation of this topic, purchase a subscription or log in.Trade Name(s)
- Hycamtin
Ther. Class.
Pharm. Class.
enzyme inhibitors
There's more to see -- the rest of this topic is available only to subscribers.
Citation
Vallerand, April Hazard., et al. "Topotecan." Davis's Drug Guide, 18th ed., F.A. Davis Company, 2023. Pediatrics Central, peds.unboundmedicine.com/pedscentral/view/Davis-Drug-Guide/51756/all/topotecan.
Vallerand AHA, Sanoski CAC, Quiring CC. Topotecan. Davis's Drug Guide. F.A. Davis Company; 2023. https://peds.unboundmedicine.com/pedscentral/view/Davis-Drug-Guide/51756/all/topotecan. Accessed September 8, 2024.
Vallerand, A. H., Sanoski, C. A., & Quiring, C. (2023). Topotecan. In Davis's Drug Guide (18th ed.). F.A. Davis Company. https://peds.unboundmedicine.com/pedscentral/view/Davis-Drug-Guide/51756/all/topotecan
Vallerand AHA, Sanoski CAC, Quiring CC. Topotecan [Internet]. In: Davis's Drug Guide. F.A. Davis Company; 2023. [cited 2024 September 08]. Available from: https://peds.unboundmedicine.com/pedscentral/view/Davis-Drug-Guide/51756/all/topotecan.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - topotecan
ID - 51756
A1 - Sanoski,Cynthia A,
AU - Vallerand,April Hazard,
AU - Quiring,Courtney,
BT - Davis's Drug Guide
UR - https://peds.unboundmedicine.com/pedscentral/view/Davis-Drug-Guide/51756/all/topotecan
PB - F.A. Davis Company
ET - 18
DB - Pediatrics Central
DP - Unbound Medicine
ER -
